Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4260 results

Sort By:

Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

Study ID: NCT04614714
Start Date: 2026-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

40

Intervention / Treatment

Nicotinamide Riboside (NR)

Placebo

Sponsor

University of California, Davis

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of an Essential Oil-Based Product System for Immune Support

Study ID: NCT07482644
Start Date: 2026-05-04
End Date: 2026-07-17
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Essential Oil Blend (Botanical Combination Product)

Placebo

Sponsor

dōTERRA International

Source: clinicaltrials.gov

Share:
Add to list

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

Study ID: NCT06426004
Start Date: 2026-04-01
End Date: 2030-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

660

Intervention / Treatment

patients will receive NPH education

primary care physicians (PCPs) will receive professional NPH education

A community health worker will assist PCP

Sponsor

Johns Hopkins Bloomberg School of Public Health

Source: clinicaltrials.gov

Share:
Add to list

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Study ID: NCT07271355
Start Date: 2026-07-01
End Date: 2031-02-28
Study Type

Interventional

Study Phase

Phase3

No. of Participants

129

Intervention / Treatment

bevacizumab

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Fluorouracil

Irinotecan Hydrochloride

Leucovorin calcium

Magnetic Resonance Imaging

Mitomycin

Administration Questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

Study ID: NCT07407673
Start Date: 2027-01-01
End Date: 2029-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Pivmecillinam

Placebo

Sponsor

Susanne Dam Nielsen, MD, DMSc

Source: clinicaltrials.gov

Share:
Add to list

Cardiac Imaging in Systemic Disorders: the ORACLES Registry

Study ID: NCT07134166
Start Date: 2026-11
End Date: 2046-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

data collection

Sponsor

Public Assistance - Paris Hospitals

Source: clinicaltrials.gov

Share:
Add to list

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Study ID: NCT07422480
Start Date: 2026-04-01
End Date: 2033-10-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

Elritercept

Alpha of the epoet

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

Study ID: NCT07447102
Start Date: 2026-04-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

96

Intervention / Treatment

BC006

Placebo

Sponsor

Dragonboat Biopharmaceutical Company Limited

Source: clinicaltrials.gov

Share:
Add to list

Reduction of Muscle Catabolism Through Brain Activation in Burn Patients

Study ID: NCT07435402
Start Date: 2026-05-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Burn-Bundle Extended Rehabilitation Program

Isoflurane Inhalational Sedation

Functional Proprioceptive Stimulation

Neurorehabilitation Techniques

Sponsor

Charles University, Czech Republic

Source: clinicaltrials.gov

Share:
Add to list

The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

Study ID: NCT07413159
Start Date: 2026-04-01
End Date: 2030-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

480

Intervention / Treatment

Pharmacists Only (Control Group)

Combined Intervention (Pharmacists + CHW Interventions)

Sponsor

Texas Southern University

Source: clinicaltrials.gov

Share:
Add to list